Interaction between human papillomavirus type 5 E2 and polo-like kinase 1

Journal of Medical Virology

Volumn 81, Issue 3, 2009, Pages 536-544

  Wang, Wei Sheng ^a   Lee, Moon Sing ^b   Tseng, Chih En ^b   Liao, I Huan ^a,c   Huang, Shu Ping ^a   Lin, Ru Inn ^a   Li, Chin ^a,b  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^b Chi General Hospital   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Bromodomain protein 4; E2; Human papillomavirus type 5; Polo like kinase 1

Indexed keywords

BROMO DOMAIN PROTEIN 4; GLYCOPROTEIN E2; POLO LIKE KINASE 1; UNCLASSIFIED DRUG; VIRUS PROTEIN; BRD4 PROTEIN, HUMAN; CELL CYCLE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; EPIDERMODYSPLASIA VERRUCIFORMIS; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 5; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SKIN EPITHELIUM; WART VIRUS; CELL LINE; CELL NUCLEUS; CHEMISTRY; KERATINOCYTE; METABOLISM; PAPILLOMA VIRUS; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN DOMAIN; TWO HYBRID SYSTEM; VIROLOGY;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 5; PAPILLOMAVIRIDAE;

CELL CYCLE PROTEINS; CELL LINE; CELL NUCLEUS; HUMANS; KERATINOCYTES; NUCLEAR PROTEINS; PAPILLOMAVIRIDAE; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; TRANSCRIPTION FACTORS; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 60049086634     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21404     Document Type: Article

References (48)

1. Abbate EA, Voitenleitner C, Botchan MR. 2006. Structure of the papillomavirus DNA-tethering complex E2: Brd4 and a peptide that ablates HPV chromosomal association. Mol Cell 24:877-889.
2. Abroi A, Ilves I, Kivi S, Ustav M. 2004. Analysis of chromatin attachment and partitioning functions of bovine papillomavirus type 1 E2 protein. J Virol 78:2100-2113.
3. Baxter MK, McBride AA. 2005. An acidic amphipathic helix in the bovine papillomavirus E2 protein is critical for DNA replication and interaction with the E1 protein. Virology 332:78-88.
4. Baxter MK, McPhillips MG, Ozato K, McBride AA. 2005. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol 79:4806-4818.
5. Berkhout RJ, Tieben LM, Smits HL, Bavinck JN, Vermeer BJ, ter Schegget J. 1995. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J Clin Microbiol 33:690-695.
6. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. 2002. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244-265.
7. Boxman IL, Berkhout RJ, Mulder LH, Wolkers MC, Bouwes Bavinck JN, Vermeer BJ, ter Schegget J. 1997. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 108:712-715.
8. Boxman IL, Mulder LH, Noya F, de Waard V, Gibbs S, Broker TR, ten Kate F, Chow LT, ter Schegget J. 2001. Transduction of the E6 and E7 genes of epidermodysplasia-verruciformis-associated human papillomaviruses alters human keratinocyte growth and differentiation in organotypic cultures. J Invest Dermatol 117:1397-1404.
9. Brannon AR, Maresca JA, Boeke JD, Basrai MA, McBride AA. 2005. Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein. Proc Natl Acad Sci USA 102:2998-3003.
10. Chan SY, Delius H, Halpern AL, Bernard HU. 1995. Analysis of genomic sequences of 95 papillomavirus types: Uniting typing, phylogeny, and taxonomy. J Virol 69:3074-3083.
11. Cogswell JP, Brown CE, Bisi JE, Neill SD. 2000. Dominant-negative polo-like kinase 1 induces mitotic catastrophe independent of cdc25C function. Cell Growth Differ 11:615-623.
12. Deau MC, Favre M, Jablonska S, Rueda LA, Orth G. 1993. Genetic heterogeneity of oncogenic human papillomavirus type 5 (HPV5) and phylogeny of HPV5 variants associated with epidermodysplasia verruciformis. J Clin Microbiol 31:2918-2926.
13. Dong G, Broker TR, Chow LT. 1994. Human papillomavirus type 11 E2 proteins repress the homologous E6 promoter by interfering with the binding of host transcription factors to adjacent elements. J Virol 68:1115-1127.
14. Elia AE, Cantley LC, Yaffe MB. 2003a. Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates. Science 299:1228-1231.
15. Elia AE, Rellos P, Haire LF, Chao JW, Ivins FJ, Hoepker K, Mohammad D, Cantley LC, Smerdon SJ, Yaffe MB. 2003b. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain. Cell 115:83-95.
16. Garcia-Alvarez B, de Carcer G, Ibanez S, Bragado-Nilsson E, Montoya G. 2007. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization. Proc Natl Acad Sci USA 104:3107-3112.
17. Garcia-Vallve S, Alonso A, Bravo IG. 2005. Papillomaviruses: Different genes have different histories. Trends Microbiol 13:514-521.
18. Golsteyn RM, Mundt KE, Fry AM, Nigg EA. 1995. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function. J Cell Biol 129:1617-1628.
19. Haller K, Stubenrauch F, Pfister H. 1995. Differentiation-dependent transcription of the epidermodysplasia verruciformis-associated human papillomavirus type 5 in benign lesions. Virology 214:245-255.
20. Hsu IW, Hsu M, Li C, Chuang TW, Lin RI, Tarn WY. 2005. Phosphorylation of Y14 modulates its interaction with proteins involved in mRNA metabolism and influences its methylation. J Biol Chem 280:34507-34512.
21. Ilves I, Maemets K, Silla T, Janikson K, Ustav M. 2006. Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol 80:3660-3665.
22. Jenson AB, Geyer S, Sundberg JP, Ghim S. 2001. Human papillomavirus and skin cancer. J Invest Dermatol Symp Proc 6:203-206.
23. Kasukawa H, Howley PM, Benson JD. 1998. A fifteen-amino-acid peptide inhibits human papillomavirus E1-E2 interaction and human papillomavirus DNA replication in vitro. J Virol 72:8166-8173.
24. Kurima K, Yang Y, Sorber K, Griffith AJ. 2003. Characterization of the transmembrane channel-like (TMC) gene family: Functional clues from hearing loss and epidermodysplasia verruciformis. Genomics 82:300-308.
25. Lai MC, Lin RI, Huang SY, Tsai CW, Tarn WY. 2000. A human importin-beta family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins. J Biol Chem 275:7950-7957.
26. Lai MC, Lin RI, Tarn WY. 2001. Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proc Natl Acad Sci USA 98:10154-10159.
27. Lai MC, Teh BH, Tarn WY. 1999. A human papillomavirus E2 transcriptional activator. The interactions with cellular splicing factors and potential function in pre-mRNA processing. J Biol Chem 274:11832-11841.
28. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. 2008. Regulation of cellular zinc balance as a potential mechanism of EVER-mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med 205:35-42.
29. Lee KS, Grenfell TZ, Yarm FR, Erikson RL. 1998. Mutation of the polobox disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc Natl Acad Sci USA 95:9301-9306.
30. Lehman CW, King DS, Botchan MR. 1997. A papillomavirus E2 phosphorylation mutant exhibits normal transient replication and transcription but is defective in transformation and plasmid retention. J Virol 71:3652-3665.
31. Li C, Lin RI, Lai MC, Ouyang P, Tarn WY. 2003. Nuclear Pnn/DRS protein binds to spliced mRNPs and participates in mRNA processing and export via interaction with RNPS1. Mol Cell Biol 23:7363-7376.
32. Lowery DM, Clauser KR, Hjerrild M, Lim D, Alexander J, Kishi K, Ong SE, Gammeltoft S, Carr SA, Yaffe MB. 2007. Proteomic screen defines the Polo-box domain interactome and identifies Rock2 as a Plk1 substrate. EMBO J 26:2262-2273.
33. McGlennen RC. 2000. Human papillomavirus oncogenesis. Clin Lab Med 20:383-406.
34. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA. 2006. Brd4 is required for E2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol 80:9530-9543.
35. McPhillips MG, Ozato K, McBride AA. 2005. Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol 79:8920-8932.
36. Mochizuki K, Nishiyama A, Jang MK, Dey A, Ghosh A, Tamura T, Natsume H, Yao H, Ozato K. 2008. The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. J Biol Chem 283:9040-9048.
37. Oliveira JG, Colf LA, McBride AA. 2006. Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci USA 103:1047-1052.
38. Qian YW, Erikson E, Li C, Maller JL. 1998. Activated polo-like kinase Plx1 is required at multiple points during mitosis in Xenopus laevis. Mol Cell Biol 18:4262-4271.
39. Ramoz N, Rueda LA, Bouadjar B, Montoya LS, Orth G, Favre M. 2002. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat Genet 32:579-581.
40. Rugg EL, McLean WH, Lane EB, Pitera R, McMillan JR, Dopping-Hepenstal PJ, Navsaria HA, Leigh IM, Eady RA. 1994. A functional "knockout" of human keratin 14. Genes Dev 8:2563-2573.
41. Schaper ID, Marcuzzi GP, Weissenborn SJ, Kasper HU, Dries V, Smyth N, Fuchs P, Pfister H. 2005. Development of skin tumors in mice transgenic for early genes of human papillomavirus type 8. Cancer Res 65:1394-1400.
42. Schweiger MR, Ottinger M, You J, Howley PM. 2007. Brd4-independent transcriptional repression function of the papillomavirus e2 proteins. J Virol 81:9612-9622.
43. Schweiger MR, You J, Howley PM. 2006. Bromodomain protein 4 mediates the papillomavirus E2 transcriptional activation function. J Virol 80:4276-4285.
44. Ushikai M, Lace MJ, Yamakawa Y, Kono M, Anson J, Ishiji T, Parkkinen S, Wicker N, Valentine ME, Davidson I, et al. 1994. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: Cooperation with activation domains of cellular transcription factors. J Virol 68:6655-6666.
45. Wu SY, Lee AY, Hou SY, Kemper JK, Erdjument-Bromage H, Tempst P, Chiang CM. 2006. Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20:2383-2396.
46. Yang Z, He N, Zhou Q. 2008. Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Mol Cell Biol 28:967-976.
47. You J, Croyle JL, Nishimura A, Ozato K, Howley PM. 2004. Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117:349-360.
48. You J, Schweiger MR, Howley PM. 2005. Inhibition of E2 binding to Brd4 enhances viral genome loss and phenotypic reversion of bovine papillomavirus-transformed cells. J Virol 79:14956-14961.